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Autism, attention deficit/hyperactivity disorder (ADHD), mental 
retardation, dyslexia, and other biologically based disorders of brain 
development affect between 400,000 and 600,000 of the 4 million 
children born in the United States each year. The Centers for Disease 
Control and Prevention (CDC) has reported that autism spectrum dis-
order (ASD) now affects 1.13% (1 of 88) of American children (CDC 
2012) and ADHD affects 14% (CDC 2005; Pastor and Reuben 2008). 
Treatment of these disorders is difficult; the disabilities they cause can 
last lifelong, and they are devastating to families. In addition, these 
disorders place enormous economic burdens on society (Trasande and 
Liu 2011). 
Although discovery research to identify the potentially preventable 
causes of neuro develop mental disorders (NDDs) has increased in recent 
years, more research is urgently needed. This research encompasses both 
genetic and environ mental studies. 
Genetic research has received particular investment and attention 
(Autism Genome Project Consortium et al. 2007; Buxbaum and Hof 
2011; Fernandez et al. 2012; O’Roak et al. 2011; Sakurai et al. 2011) 
and has demonstrated that ASD and certain other NDDs have a 
strong hereditary component (Buxbaum and Hof 2011; Sakurai et al. 
2011). Linkage studies have identified candidate autism susceptibility 
genes at multiple loci, most consistently on chromosomes 7q, 15q, and 
16p (Autism Genome Project Consortium et al. 2007; Sakurai et al. 
2011). Exome sequencing in sporadic cases of autism has detected 
new mutations (O’Roak et al. 2011), and copy number variant studies 
have identified several hundred copy number variants putatively linked 
to autism (Fernandez et al. 2012). The candidate genes most strongly 
implicated in NDD causation encode for proteins involved in synaptic 
architecture, neuro transmitter synthesis (e.g., g-amino butyric acid 
serotonin), oxytocin receptors, and cation trafficking (Sakurai et al. 
2011). No single anomaly predominates. Instead, autism appears to 
be a family of diseases with common pheno types linked to a series of 
genetic anomalies, each of which is responsible for no more than 2–3% 
of cases. The total fraction of ASD attributable to genetic inheri tance 
may be about 30–40%.
Exploration of the environmental causes of autism and other NDDs 
has been catalyzed by growing recognition of the exquisite sensitivity 
of the developing human brain to toxic chemicals (Grandjean and 
Landrigan 2006). Th is susceptibility is greatest during unique “windows 
of vulnerability” that open only in embryonic and fetal life and have 
no later counter part (Miodovnik 2011). “Proof of the principle” that 
early exposures can cause autism comes from studies linking ASD to 
medications taken in the first trimester of pregnancy—thalidomide, 
misoprostol, and valproic acid—and to first-trimester rubella infection 
(Arndt et al. 2005; Daniels 2006). 
This “proof-of-principle” evidence for environmental causation is 
supported further by findings from prospective birth cohort epidemio-
logical studies, many of them supported by the National Institute 
of Environmental Health Sciences (NIEHS). These studies enroll 
women during pregnancy, measure prenatal exposures in real time 
as they occur, and then follow children longitudinally with periodic 
direct examinations to assess growth, development, and the presence 
of disease. Prospective studies are powerful engines for the discovery 
of etiologic associations between prenatal exposures and NDDs. 
They have linked autistic behaviors with prenatal exposures to the 
organophosphate insecticide chlorpyrifos (Eskenazi et al. 2007) and 
also with prenatal exposures to phthalates (Miodovnik et al. 2011). 
Additional prospective studies have linked loss of cognition (IQ), 
dyslexia, and ADHD to lead (Jusko et al. 2008), methyl mercury 
(Oken et al. 2008), organophosphate insecticides (London et al. 2012), 
organo chlorine insecticides (Eskenazi et al. 2008), polychlorinated 
biphenyls (Winneke 2011), arsenic (Wasserman et al. 2007), manganese 
(Khan et al. 2011), polycyclic aromatic hydrocarbons (Perera et al. 
2009), bisphenol A (Braun et al. 2011), brominated flame retardants 
(Herbstman et al. 2010), and perfluorinated compounds (Stein and 
Savitz 2011).
Toxic chemicals likely cause injury to the developing human brain 
either through direct toxicity or inter actions with the genome. An 
expert committee convened by the U.S. National Academy of Sciences 
(NAS) estimated that 3% of neuro behavioral disorders are caused 
directly by toxic environ mental exposures and that another 25% 
are caused by inter actions between environmental factors, defined 
broadly, and inherited susceptibilities (National Research Council 
2000). Epigenetic modification of gene expression by toxic chemicals 
that results in DNA methyla tion, histone modification, or changes 
in activity levels of non-protein-coding RNA (ncRNAs) may be a 
mechanism of such gene–environment interaction (Grafodatskaya 
et al. 2010). Epigenetic “marks” have been shown to be able to 
influence gene expression and alter high-order DNA structure (Anway 
and Skinner 2006; Waterland and Jirtle 2004).
A major unanswered question is whether there are still undiscov-
ered environ mental causes of autism or other NDDs among the thou-
sands of chemicals currently in wide use in the United States. In the 
past 50 years, > 80,000 new synthetic chemicals have been developed 
(Landrigan and Goldman 2011). The U.S. Environmental Protection 
Agency has identified 3,000 “high production volume” (HPV) chemi-
cals that are in widest use and thus pose greatest potential for human 
exposure (Goldman 1998). These HPV chemicals are used today 
in millions of consumer products. Children and pregnant women 
are exposed extensively to them, and CDC surveys detect quantifi-
able levels of nearly 200 HPV chemicals in the bodies of virtually all 
Americans, including pregnant women (Woodruff et al. 2011). 
The significance of early chemical exposures for children’s health 
is not yet fully understood. A great concern is that a large number of 
the chemicals in widest use have not undergone even minimal assess-
ment of potential toxicity, and only about 20% have been screened for 
potential toxicity during early development (Landrigan and Goldman 
2011). Unless studies specifically examine develop mental consequences 
of early exposures to untested chemicals, sub clinical dysfunction caused 
by these exposures can go unrecognized for years. One example is the 
“silent epidemic” of childhood lead poisoning: From the 1940s to the 
1980s, millions of American children were exposed to excessive levels of 
lead from paint and gasoline, resulting in reduced average intelligence 
by 2–5 IQ points (Grosse et al. 2002). The late David Rall, former 
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director of NIEHS, once observed that “If thalidomide had caused a 
10-point loss of IQ instead of birth defects of the limbs, it would likely 
still be on the market” (Weiss 1982). 
To begin formulation of a systematic strategy for discovery of 
potentially preventable environmental causes of autism and other 
NDDs, the Mount Sinai Children’s Environmental Health Center, 
with the support of the NIEHS and Autism Speaks, convened a work-
shop on “Exploring the Environmental Causes of Autism and Learning 
Disabilities.” This workshop produced a series of papers by leading 
researchers, some of which are published in this issue of Environmental 
Health Perspectives. It also generated a list of 10 chemi cals and mixtures 
widely distributed in the environment that are already suspected of 
causing develop mental neuro toxicity: 
Lead (Jusko et al. 2008)•	
Methylmercury (Oken et al. 2008)•	
Polychlorinated biphenyls (Winneke 2011)•	
Organophosphate pesticides (Eskenazi et al. 2007; London et al. •	
2012)
Organochlorine pesticides (Eskenazi et al. 2008)•	
Endocrine disruptors (Braun et al. 2011; Miodovnik et al. 2011)•	
Automotive exhaust (Volk et al. 2011) •	
Polycyclic aromatic hydrocarbons (Perera et al. 2009)•	
Brominated flame retardants (Herbstman et al. 2010)•	
Perfluorinated compounds (Stein and Savitz 2011).•	
This list is not exhaustive and will almost certainly expand in the 
years ahead as new science emerges. It is intended to focus research in 
environmental causation of NDDs on a short list of chemicals where 
concentrated study has high potential to generate actionable findings in 
the near future. Its ultimate purpose is to catalyze new evidence-based 
programs for prevention of disease in America’s children. 
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